Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab is a research paper published in Ophthalmology Retina (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: F30 HL168842
NICHD NIH HHS
Grant: U24 HD113136
NHLBI NIH HHS
Grant: K24 HL148181
NIA NIH HHS
Grant: R01 AG068002
NLM NIH HHS
Grant: R01 LM013426
NEI NIH HHS
Grant: K23 EY033440
NIDDK NIH HHS
Grant: K23 DK132459
NEI NIH HHS
Grant: K23 EY032985
NLM NIH HHS
Grant: R01 LM006910
NCATS NIH HHS
Grant: UL1 TR003098
NEI
FWCI
7.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals